RxDoctor Payments Data

Ashley Partin, NP

Family · Brookville, INNPI 1447732474

Payments from drug & device makers

$671in general payments, 2019–2025

Across 39 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$160
  • Exact Sciences$86
  • Amgen$74
  • Novo Nordisk$66
  • GSK$62
  • Collegium Pharmaceutical, Inc.$41
  • plus $182 from 10 others

What the payments were for

  • Food & beverage$671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$671 in reported general payments places this provider in the 60th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$37,305
Medicare patients
92
Services billed
591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$41,646
FarxigaDapagliflozin Propanediol31$39,047
OzempicSemaglutide40$35,534
EliquisApixaban50$35,372
XareltoRivaroxaban17$24,485
TrulicityDulaglutide24$22,809
JardianceEmpagliflozin23$20,305
MounjaroTirzepatide20$20,039
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,484
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$7,831
Breo ElliptaFluticasone/Vilanterol19$7,521
Albuterol Sulfate HfaAlbuterol Sulfate108$2,858
Ventolin HfaAlbuterol Sulfate24$1,336
LantusInsulin Glargine,hum.Rec.Anlog17$1,190
Duloxetine Hcl66$1,007

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$62$49,16863 claims
Lilly USA, LLCTrulicity, Mounjaro$14$42,84844 claims
Novo NordiskOzempic$66$35,53440 claims
PfizerEliquis$13$35,37250 claims
AbbVieSynthroid$160$37413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,392 family providers in Indiana.

Other family in Brookville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →